NHS England Innovative Drug Scorecard Paints Unbalanced, Unclear Access Picture
This article was originally published in Scrip
Executive Summary
Latest collected data of patient access in England to recently launched drugs again shows low uptake of such therapies and underscores the need for revamping the way modern medicines are made available to patients in the UK, according to the Association of the British Pharmaceutical Industry.